biomarkers Related News
A new blood test to improve epilepsy diagnosis
Researchers have found that levels of immune proteins in the blood are higher before and after an epileptic seizure, a discovery which may facilitate...
Blood test developed to distinguish patients with frontotemporal dementia
Scientists have demonstrated, for the first time, that a blood test is able to detect frontotemporal dementia.
Researchers from the University of Eastern Finland have...
Underlying neurodegeneration could be revealed by simple blood test
The presence of underlying neurodegeneration in people with cognitive issues can be identified by a single biomarker, research has revealed.
Researchers from King’s College London...
COLOSSUS: The first patient recruited in translational trial for metastatic colorectal cancer
EU-funded Horizon 2020 translational trial could lead to revolutionary treatment for advanced metastatic colorectal cancer.
The University Hospital Mannheim, Germany, has recruited the first patient...
Enhancing analysis of clinical biomarkers in medicine
Published in Genomic Medicine, researchers present new genetic testing technology which enhances precision of analysis of clinical biomarkers in medicine.
A team of researchers from...
Biomarker for colorectal cancer symptoms may be on the horizon
Johns Hopkins researchers have identified a protein biomarker involved in the development of new blood vessels that could identify colorectal cancer symptoms.
In laboratory studies,...
Have medical studies found a way to reverse ageing?
Research data from human medical studies combined with analytical approaches from physics offer a whole new concept to understand and maybe even reverse ageing.
Ageing...
Chemical modification of paper for analytical devices
Find out how light-based chemical modification protocols of paper are paving the way for paper microfluidics and lateral flow assays.
Paper-based microfluidics and lateral flow...
Challenges and opportunities in cancer drug development
Managing director Professor Heinz Zwierzina of the Cancer Drug Development Forum talks Health Europa through the challenges in the search for new cancer drugs.
The...
sphingotec to launch biomarkers addressing unmet medical need
sphingotec GmbH is set to launch first-in-class blood biomarker point-of-care tests that allow early diagnosis and monitoring of disorders caused by acute kidney dysfunction...
The immune landscape of breast cancer
At the University of Turku, Maija Hollmén, PhD, is helping to elucidate the significance of macrophage-expressed Clever-1 in defining the immune cell composition in...
The Precision Medicine and Biomarkers Leaders Summit 2018
Leading pharmaceutical and biotech companies worldwide are gathering for the Precision Medicine and Biomarkers Leaders Summit 2018. We provide an overview of the event.
In...
Biomarker technology wins innovation prize
A pioneering blood testing biomarker technology has been recognised as one of the health innovations of the year by the Health Awards 2018.
The new...
